JPRN-jRCT2080221482
Unknown
Phase 1
Phase I/II trial of chemoradiotherapy concurrent with Satraplatin in renal impairment patients with squamous cell carcinoma of the head and neck
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Yakult Honsha Co.,Ltd.
- Enrollment
- 33
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •(1\) Histologically proven squamous cell carcinoma
- •(2\) Primary lesion located at oropharynx, hypopharynx, or larynx
- •(3\) Unresectable locally advanced head and neck cancer
- •(4\) ECOG performance status (PS) :0\-1
- •(5\) Calculated creatinine clearance \> 25 mL/min, \< 60 mL/min
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 1
Phase I/II trial of chemoradiotherapy concurrent with S-1 and cisplatin in patients with clinical stage II/III esophageal carcinoma (JCOG0604)JPRN-jRCT2091220010Japan Clinical Oncology Group(JCOG)81
Completed
Phase 3
A phase I/II trial of chemoradiotherapy concurrent with S-1 plus mitomycin C in patients with clinical stage II/III squamous cell carcinoma of the anal canal (JCOG0903, SMART-AC)anal canal canerJPRN-UMIN000003237Japan Clinical Oncology Group(JCOG)71
Completed
Phase 2
A phase II trial of concurrent chemoradiotherapy with 5-FU plus cisplatin for resectable squamous cell carcinoma of cervical esophaguscervical esophageal cancerJPRN-UMIN000001439ational Cancer Center Hospital32
Recruiting
N/A
Clinical trial of concurrent chemoradiotherapy with Docetaxel, Cisplatin and 5-Fluorouracil (TPF) in patients with locally advanced head and neck squamous cell carcinomaocally advanced head and neck squamous cell carcinomaJPRN-UMIN000021841Yokohama City University hospital50
Completed
Phase 2
Phase II study of concurrent chemoradiotherapy with weekly cisplatin and paclitaxel chemotherapy for locally advanced cervical carcinoma (JACCRO GY-01)terine cervical carcinomaJPRN-UMIN000002937Japanese Cancer Clinical Research Organization(JACCRO)70